Assignments got your hair on fire?

Douse the flames with our full-range writing service!

Experienced academic writing professionals are at your fingertips. Use this handy tool to get a price estimate for your project.

HLA-B*5701 Screening for Hypersensitivity to Abacavir - …

Capecitabine is an orally administered prodrug of the pyrimidine analog 5-flourouracil (5-FU), which is used frequently in the treatment of metastatic breast cancer. Capecitabine is enzymatically converted to 5-FU, and inhibits DNA synthesis within tumors, thereby slowing growth. Dihydropyrimidine dehydrogenase (DPD), an enzyme encoded by DPYD, is the rate-limiting step in pyrimidine catabolism and deactivates more than 80% of standard doses of 5-FU and the oral 5-FU prodrug capecitabine (). Up to 5% of the population lacks the DPD enzyme, and this has been associated with excess drug accumulation and toxicity (). Additionally, an estimated 3% to 5% of the population has sequence variations in DPYD, and these pharmacogenetic variants may be linked with 5-FU toxicity. Multiple DPYD variants have been identified, including well-known non-synonymous and splice site variations within the coding regions of the gene, and more novel variations within noncoding regions (), and their association with 5-FU toxicity has been replicated in multiple studies. Future metabolic profiling of patients and comprehensive genetic screening of DPYD has been proposed to further refine the understanding of relative contribution of individual DPYD variants to the risk of severe 5-FU-related toxicity ().

While variants in several genes encoding for tamoxifen metabolizing enzymes have been correlated with tamoxifen-associated outcomes (). Variable activity of the pertinent cytochrome P450 enzymes (CYP), brought about by genetic polymorphisms and drug interactions, may alter the balance of tamoxifen metabolites, thereby altering its effects. While there are several genes of interest in tamoxifen’s metabolism, the one that has generated the most press has been CYP2D6, which encodes the enzyme responsible for metabolism of N-desmethyl-tamoxifen to endoxifen. CYP2D6 is a polymorphic gene with more than 100 reported allelic variants, often due to SNPs (). Common allelic variants in this gene are associated with the extent of N-desmethyl-tamoxifen metabolism and subsequently with in vivo concentrations of endoxifen. This observation has led to the hypothesis that allelic variation may predict responsiveness to therapy with tamoxifen. This theory has generated great interest, studies and even practice changes over the last decade. In general, patients have been classified as extensive, intermediate or poor metabolizers based upon their CYP2D6 allelic variants.

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

October 2011 - Volume 36 - Issue 10

The anthracyclines doxorubicin and epirubicin have been widely used in breast cancer treatment for several decades. This class of drugs inhibits topoisomerase II and thereby induces apoptosis of cells. Pharmacogenetic variations have been observed in genes encoding for anthracycline-metabolizing enzymes, drug transporters, and enzymes influencing oxidative stress and apoptosis (). Approximately 50% of infused doxorubicin is eliminated in its intact form. The metabolism of remainder of doxorubicin is complex and involves a variety of enzymes, principally aldoketoreductase (AKR1A1), carbonyl reductases (CBR1 and CBR3), NADH dehydrogenase (NQO1), and nitric oxide synthases (NOS1, NOS2 and NOS3).

Pharmacogenetics and the pharmacological management ..

Versatile Services that Make Studying Easy
We write effective, thought-provoking essays from scratch
We create erudite academic research papers
We champion seasoned experts for dissertations
We make it our business to construct successful business papers
What if the quality isn’t so great?
Our writers are sourced from experts, and complete an obstacle course of testing to join our brigade. Ours is a top service in the English-speaking world.
How do I know the professor won’t find out?
Everything is confidential. So you know your student paper is wholly yours, we use CopyScape and WriteCheck to guarantee originality (never TurnItIn, which professors patrol).
What if it doesn’t meet my expectations?
Unchanged instructions afford you 10 days to request edits after our agreed due date. With 94% satisfaction, we work until your hair is comfortably cool.
Clients enjoy the breezy experience of working with us
Click to learn our proven method

or a combination of both for CYP450 enzymes


89%
of clients claim significantly improved grades thanks to our work.
98%
of students agree they have more time for other things thanks to us.
Clients Speak
“I didn’t expect I’d be thanking you for actually improving my own writing, but I am. You’re like a second professor!”